Targeting p90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting p90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers
Authors
Keywords
-
Journal
STEM CELLS
Volume 30, Issue 7, Pages 1338-1348
Publisher
Wiley
Online
2012-06-05
DOI
10.1002/stem.1128
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- YB-1 Bridges Neural Stem Cells and Brain Tumor-Initiating Cells via Its Roles in Differentiation and Cell Growth
- (2011) A. Fotovati et al. CANCER RESEARCH
- Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression
- (2011) M. Shiota et al. ENDOCRINE-RELATED CANCER
- YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth
- (2011) Annette Lasham et al. JNCI-Journal of the National Cancer Institute
- YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification
- (2011) A H Davies et al. ONCOGENE
- Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing
- (2011) P. N. I. Lau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional Viability Profiles of Breast Cancer
- (2011) R. Brough et al. Cancer Discovery
- Y-Box Binding Protein-1 Induces the Expression ofCD44andCD49fLeading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance
- (2010) Karen To et al. CANCER RESEARCH
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- The promise and challenges of targeting RSK for the treatment of cancer
- (2010) Anna L Stratford et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer
- (2010) Anna L. Stratford et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells
- (2010) Sumin Kang et al. JOURNAL OF CLINICAL INVESTIGATION
- Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer
- (2010) Tony Blick et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics
- (2010) Anna Maria Calcagno et al. JNCI-Journal of the National Cancer Institute
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability
- (2010) Jennifer H. Law et al. PLoS One
- Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells
- (2009) M Murohashi et al. BRITISH JOURNAL OF CANCER
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Fibroblast Growth Factor Receptor 3 Associates with and Tyrosine Phosphorylates p90 RSK2, Leading to RSK2 Activation That Mediates Hematopoietic Transformation
- (2009) S. Kang et al. MOLECULAR AND CELLULAR BIOLOGY
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast Cancer Stem Cells and Intrinsic Subtypes: Controversies Rage On
- (2009) Harikrishna Nakshatri et al. Current Stem Cell Research & Therapy
- Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
- (2008) J. H. Law et al. CANCER RESEARCH
- The RSK factors of activating the Ras/MAPK signaling cascade
- (2008) Audrey Carriere Frontiers in Bioscience-Landmark
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- The RSK family of kinases: emerging roles in cellular signalling
- (2008) Rana Anjum et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now